Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03263026
Title Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Denovo Biopharma LLC
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Prednisone + Rituximab + Vincristine Sulfate

Enzastaurin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.